Document is current
Any future updates will be listed below
-
Authors
Valensin, Carlotta
Côté, Emilie J. M.
Pereira-Carvalho, Daniela
Gardner, Rachael A.
Nishku, Glen
Giles, Caitlin L.
Gill, Carolyn
Brockbank, Anna
Story, Lisa
Shennan, Andrew H.
Suff, Natalie
Gibbons, Deena L.
Tribe, Rachel M.
-
Funding
Funding for this research was provided by:
Leona M. and Harry B. Helmsley Charitable Trust
Borne Foundation
Medical Research Council (MR/X000257/1)
Medical Research Council (MR/X000257/1)
Medical Research Council (MR/X000257/1)
Medical Research Council (MR/X000257/1)
Medical Research Council (MR/X000257/1)
Medical Research Council (MR/X000257/1)
Rosetrees Trust (CF-2023-M-2-104)
Rosetrees Trust (CF-2023-M-2-104)
Rosetrees Trust (CF-2023-M-2-104)
Rosetrees Trust (CF-2023-M-2-104)
Centre for Translational Medicine, King's Health Partners
Pregnolia AG
Wellcome Trust (222970/Z/21/Z)
Wellcome Trust (222970/Z/21/Z)
- License Information
-
More Information
Article History
Received: 9 October 2024
Accepted: 14 November 2024
First Online: 28 November 2024
Declarations
:
: National regulatory approval for the INSIGHT-2 study was obtained from the cosponsors GSTT and KCL (IRAS reference: 326577). The study successfully obtained approval from the West of Scotland Research Ethics Service (WoSRES) (REC reference: 23/WS/0114) and the HRA and Health and Care Research Wales (HCRW). Participants provide written informed consent (see section).
: All authors have reviewed and approved the manuscript for publication.
: The authors declare that they have no competing interests, but AHS and NS received a research grant from a commercial collaborator (Pregnolia AG).
